Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aeglea BioTherapeutics In...

    NASDAQ: AGLE · Real-Time Price · USD
    12.01
    0.75 (6.66%)
    At close: Nov 27, 2023, 10:00 PM

    Aeglea BioTherapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -208.02M -83.81M -65.8M
    Depreciation & Amortization
    		 -11.4M 1.57M 1.58M
    Stock-Based Compensation
    		 44.83M 7.11M 8.04M
    Other Working Capital
    		 n/a -2.86M 768K
    Other Non-Cash Items
    		 n/a 496K 434K
    Deferred Income Tax
    		 n/a n/a 204K
    Change in Working Capital
    		 n/a -5.5M 1.83M
    Operating Cash Flow
    		 -157.41M -80.14M -53.72M
    Capital Expenditures
    		 n/a -38K -573K
    Cash Acquisitions
    		 n/a 428K -344K
    Purchase of Investments
    		 -599.25M -39.5M -133.08M
    Sales Maturities Of Investments
    		 245.97M 96.55M 111.03M
    Other Investing Acitivies
    		 n/a -428K 344K
    Investing Cash Flow
    		 -353.29M 57.01M -22.62M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 242.06M 42.68M 1.39M
    Financial Cash Flow
    		 410.91M 42.68M 1.39M
    Net Cash Flow
    		 -99.79M 19.44M -74.96M
    Free Cash Flow
    		 -157.41M -80.18M -54.29M

    Add to Watchlist